Navigation Links
Vion Pharmaceuticals to Present at 20th Annual Bear Stearns Healthcare Conference
Date:9/10/2007

is news release contains forward-looking statements. Such statements are subject to certain risk factors which may cause Vion's plans to differ or results to vary from those expected, including Vion's potential inability to obtain regulatory approval for its products, delayed or unfavorable results of drug trials, the possibility that favorable results of earlier preclinical studies or clinical trials are not predictive of safety and efficacy results in later clinical trials, the need for additional research and testing, the potential inability to secure external sources of funding to continue operations, the inability to access capital and funding on favorable terms, continued operating losses and the inability to continue operations as a result, and a variety of other risks set forth from time to time in Vion's filings with the Securities and Exchange Commission, including but not limited to the risks attendant to the forward-looking statements included under Item 1A, "Risk Factors" in Vion's Annual Report on Form 10-K for the year ended December 31, 2006 and the Company's Form 10-Q for the quarter ended June 30, 2007. In particular, there can be no assurance as to the results of any of the Company's clinical trials, that any of these trials will continue to full accrual, or that any of these trials will not be discontinued, modified, delayed or ceased altogether. Except in special circumstances in which a duty to update arises under law when prior disclosure becomes materially misleading in light of subsequent events, Vion does not intend to update any of these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

COMPANY CONTACT: Vion Pharmaceuticals, Inc.

Alan Kessman, Chief Executive Officer

Howard B. Johnson, President & CFO

(203)498-4210


'/>"/>
SOURCE Vion Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
4. Wisconsin firms to present at Cleantech venture capital event
5. New Sonic Foundry search engine finds words, phrases in video presentations
6. Lone Wisconsin firm to present at InvestMidwest
7. Sonic Foundry creates search engine for 7,000 expert video presentations
8. InvestMidWest calls for business presentations
9. Wicab to present BrainPort at Boston conference
10. Three more Wisconsin firms to present at venture forum
11. Six Wisconsin firms to present at BIO Mid-America VentureForum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... Cystic fibrosis (CF) is a genetic ... gastrointestinal organs. In particular, very thick mucus accumulates in ... difficult to clear, occludes the airways, and creates an ... frequently suffer from chronic biofilm infections, and ultimately succumb ... approach to treating the major challenges in the lungs ...
(Date:10/2/2014)... Mich. (PRWEB) October 02, 2014 MS ... with Hile Creative to refine its marketing approach. Backed ... MS Bioworks serves researchers in the biological sciences, including ... Bioworks has already seen substantial growth over the past ... with current customers, the company plans to launch a ...
(Date:10/2/2014)... (PRWEB) October 02, 2014 At a time ... Bel-Art Products has introduced a new kind of squeeze ... market is the Scienceware® Squeeze Rite™ Wash Bottle , ... tube position within the bottle reduces the waste of reagents, ... of those liquids. , “Easier to squeeze when compared to ...
(Date:10/2/2014)... CARLOS, Calif. and BRIDGEWATER, ... Corporation (NYSE: XON) , a leader in synthetic ... seventh largest generic drug manufacturer by volume in ... second Exclusive Channel Collaboration (ECC) for a target ... expression system, the goal of the collaboration is ...
Breaking Biology Technology:Synedgen to Present at North American Cystic Fibrosis Conference 2Synedgen to Present at North American Cystic Fibrosis Conference 3Hile Creative to Provide Copywriting and Graphic Design Services for MS Bioworks 2New Wash Bottle Reduces Waste of Reagents, Solutions, and Other Liquids 2Intrexon and Amneal Expand Relationship with Second Product Collaboration 2Intrexon and Amneal Expand Relationship with Second Product Collaboration 3
... Wis . - The Medical College of Wisconsin ... National Institute of Neurological Disorders and Stroke ... , ,The research, which will be led by principal ... examine the link between oxygen deficit and loss of ...
... Green Bay, Wis. - For six years, Steve Matheys served ... experience during that period - 1998 to 2004 - convinced him ... for bigger and better things in the executive suite. , ,Provided ... is. , ,Matheys, who now serves as executive vice president of ...
... Milwaukee, Wis . - He is fast becoming one of ... and if he has his way chief information officers and ... when they move to fill IT staff openings. , ... during the Wisconsin Entrepreneur's Conference in Milwaukee, is ...
Cached Biology Technology:Visions: Matheys says CIO role is good training for executive suite 2Visions: Matheys says CIO role is good training for executive suite 3Visions: Matheys says CIO role is good training for executive suite 4Jump starting technology education 2Jump starting technology education 3
(Date:9/30/2014)... farm runoff in Hawaii is causing tumors in endangered ... study, published Tuesday in the peer-reviewed open-access journal ... up in algae that the turtles eat, promoting the ... internal organs. , Scientists at Duke University, the University ... (NOAA) conducted the study to better understand the causes ...
(Date:9/30/2014)... Munich report that a new class of chemical ... drugs. They have also pinpointed the relevant target ... agents. , Researchers led by LMU,s Professor ... Technische Universitt Mnchen have identified a class of ... the fight against malignant tumors. The compound is ...
(Date:9/30/2014)... pregnanteven with IVF? Here,s some hope: A new research ... The FASEB Journal , explains how scientists developed ... PAWP, which induced embryo development in human and mouse ... by the sperm cell during fertilization. , "We believe ... paradigm shift in our understanding of human fertilization by ...
Breaking Biology News(10 mins):Pollution linked to lethal sea turtle tumors 2Pollution linked to lethal sea turtle tumors 3Cancer therapy: Driving cancer cells to suicide 2Synthetic sperm protein raises the chance for successful in vitro fertilization 2
... dinner fat intake seem to influence negatively the sleep pattern ... be presented on Tuesday at SLEEP 2008, the 22nd Annual ... study, authored by Cibele Crispim, of the Federal University of ... 20-45 years of age, whose food intake was analyzed by ...
... forensic scientists at the University of Copenhagen has studied human ... to the iron age, and discovered a man who appears ... beings were as genetically diverse 2000 years ago as they ... than was previously thought. The findings also suggest that people ...
... A new book, Grounds for Knowledge , ... modern buildings and the striking landscape that surrounds them. ... L. Watson, who, together with her husband James D. Watson ... picturesque grounds of CSHL for almost four decades. The ...
Cached Biology News:Fat intake negatively influences the sleep pattern in healthy adults 2New research refutes myth of pure Scandinavian race 2New research refutes myth of pure Scandinavian race 3
Request Info...
... Universal Amplicon Detection Assay (ADA) ... the qualitative detection and quantitation ... in vitro nucleic acid amplification. ... to be used in diagnostic ...
{3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide}. ,250 ug/ml Propidium Iodide (PI) in PBS....
... DNAzol Reagents are complete ready-to-use reagents for ... Reagent is specifically formulated for the isolation ... Reagent is specifically formulated for the isolation ... isolated with DNAzol Reagents can be used ...
Biology Products: